S

START | Barcelona

Research site

(Unclaimed)

Location

Avinguda de Vallcarca 151, Barcelona, Barcelona, Spain

Site insights

Top conditions

Top treatments

Tavapadon

Emricasan

Ribavirin

ARGX-113

Anecortave Acetate

Telaprevir

CVL-865

Peginterferon

TX000045

PPSGG

Parent organization

This site is a part of START

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

TX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045...

Enrolling

Heart Failure With Preserved Ejection Fraction

Pulmonary Hypertension

Drug: TX000045- Dose A

Drug: TX000045- Dose B

Open-label Trial in Parkinson's Disease (PD) (TEMPO-4)

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Park...

Active, not recruiting

Parkinson Disease

Drug: Tavapadon